Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Remedium Lifecare Q4 Results: Loss Increases by Over 1000% Year Over Year

Reading Time: < 1 minute

Remedium Lifecare, a leading pharmaceutical company, recently announced their fourth-quarter results for the fiscal year 2024. The results, declared on 27th May, 2024, revealed some significant changes in the company’s financial performance.

The total revenue for the quarter stood at ₹1408.49 Cr, showing a decline of 23.21% compared to the previous quarter. However, on a year-on-year basis, the revenue saw a staggering increase of 1763.59%. The company reported a net loss of ₹-53.72 Cr for Q4, marking a significant increase of 217.25% from the previous quarter.

Operating income took a hit, decreasing by 146.73% quarter-on-quarter and a massive 1004.48% year-on-year. The Diluted Normalized EPS for Q4 was reported at ₹-149.22, reflecting a substantial decrease of 25988.78% compared to the same period last year.

In terms of market performance, Remedium Lifecare delivered a negative return of -8.49% in the last week, -21.59% in the last six months, and -26.9% year-to-date. The company currently has a market capitalization of ₹738.86 Cr, with a 52-week high/low of ₹179.66 and ₹66.85 respectively.

Investors and analysts are closely monitoring the financials of Remedium Lifecare, given the fluctuations in revenue and profitability. The company’s performance in the upcoming quarters will be crucial in determining its future trajectory in the pharmaceutical industry. Stay tuned for more updates on Remedium Lifecare and its market performance.

Taylor Swifts New Album Release Health issues from using ACs Boston Marathon 2024 15 Practical Ways To Save Money